Luke Riggan
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- IL-33, ST2, and ILC Pathways
- T-cell and B-cell Immunology
- Immune cells in cancer
- Immune responses and vaccinations
- Reproductive System and Pregnancy
-
- CAR-T cell therapy research
Papers in
-
- Immune Cell Function and Interaction 8
- IL-33, ST2, and ILC Pathways 3
- T-cell and B-cell Immunology 2
- Reproductive System and Pregnancy 2
- Oncology 6
- CAR-T cell therapy research 4
- Co-authors
- Timothy E. O’Sullivan (9 shared papers)Andrew D. Hildreth (4 shared papers)Aharon G. Freud (1 shared paper)Akira Shibuya (1 shared paper)Tsukasa Nabekura (1 shared paper)Orr-El Weizman (1 shared paper)Eric Song (1 shared paper)James R. Carlyle (1 shared paper)
- Journals
- Nature Immunology (4 papers)Molecular Cancer Research (2 papers)Trends in Immunology (1 paper)Frontiers in Oncology (1 paper)Cell Reports (1 paper)
- Partner nations
- United StatesSouth AfricaChina
In The Last Decade
Luke Riggan
14 papers receiving 446 citations
Peers
Comparison fields: 5 of 62
- Immunology 344
- Oncology 82
- Obstetrics and Gynecology 15
- Surgery 82
- Hematology 15
Countries citing papers authored by Luke Riggan
This map shows the geographic impact of Luke Riggan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Riggan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Riggan more than expected).
Fields of papers citing papers by Luke Riggan
This network shows the impact of papers produced by Luke Riggan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Riggan. The network helps show where Luke Riggan may publish in the future.
Co-authors
The 25 scholars most cited alongside Luke Riggan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 94 | |
| 2 | 2019 | 72 | |
| 3 | 2023 | 56 | |
| 4 | 2021 | 54 | |
| 5 | 2019 | 50 | |
| 6 | 2020 | 28 | |
| 7 | 2024 | 21 | |
| 8 | 2022 | 17 | |
| 9 | 2017 | 15 | |
| 10 | 2020 | 13 | |
| 11 | 2022 | 12 | |
| 12 | 2020 | 9 | |
| 13 | 2022 | 6 | |
| 14 | 2017 | 2 |
About Luke Riggan
Luke Riggan is a scholar working on Immunology, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 14 papers that have together received 449 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (8 papers), CAR-T cell therapy research (4 papers), IL-33, ST2, and ILC Pathways (3 papers), CRISPR and Genetic Engineering (3 papers), Prostate Cancer Treatment and Research (2 papers), T-cell and B-cell Immunology (2 papers), Reproductive System and Pregnancy (2 papers) and Cytomegalovirus and herpesvirus research (2 papers). The work is most often cited by research in Immunology (344 citations), Oncology (82 citations), Obstetrics and Gynecology (15 citations), Surgery (82 citations) and Hematology (15 citations). Luke Riggan has collaborated with scholars based in United States, South Africa and China. Frequent co-authors include Timothy E. O’Sullivan, Andrew D. Hildreth, Aharon G. Freud, Akira Shibuya, Tsukasa Nabekura, Orr-El Weizman, Eric Song, James R. Carlyle, Christina S. Leslie and Chirag Krishna. Their work appears in journals such as Nature Immunology, Molecular Cancer Research, Trends in Immunology, Frontiers in Oncology and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.